PRAX 外匯新聞
Praxis Precision Inks Licensing Deal With Tenacia Biotechnology For Ulixacaltamide In China
Biopharmaceutical company Praxis Precision Medicines, Inc. (PRAX) announced Friday an exclusive collaboration and license agreement with China-based clinical-stage biopharmaceutical company Tenacia Biotechnology (Shanghai) Company, Ltd.
RTTNews
|
999天前
